Literature DB >> 27906155

[Prevalence of Hypothyroidism in Andalusia, Spain, Determined by Thyroid Hormone Comsumption].

José Escribano-Serrano1, José Mancera-Romero2, Vanessa Santos-Sánchez3, Carolina Payá-Giner4, Mª Isabel Méndez-Esteban4, Antonio García-Bonilla5, Manuela Márquez-Ferrando6, Antonio Hormigo-Pozo7, Alfredo Michán-Doña8.   

Abstract

OBJECTIVE: Hypothyroidism is the most common condition linked to a hormone deficiency, nevertheless data on its prevalence are scarce in Spain. For that reason, we have estimated its prevalence through the registration of patients who had used thyroid hormones in Andalusia (South Spain).
METHODS: Data of patients who had withdrawn levothyroxine under the public system during 2014 from the base of the Andalusian Health Service were considered. Prevalence were calculated with confidence intervals of 95% for each management area, stratified by sex and age groups, and differences between them were evaluated.
RESULTS: 321,368 people (98% older than 18 years and 83% female) were identified as levothyroxine users and a prevalence of hypothyroidism of 3.95% (95%CI:3.94-3.96) was estimated for the general population. The condition was more common in females, in the older 18 years 7.81% (95%CI:7.80 to 7.82) compared to males 1.75% (95%CI:1.73-1.77) with a ratio of 4.5-fold. It increases in the population of women older than 45 years, 10.32% (95%CI:10.30-0.32) and in the over 60 years 11.37% (95%CI: 11.35-11.40). The prevalence in adult women in the western provinces is 7.38% (95%CI:7.36-7.40), in the eastern provinces 8.59% (95%CI:8.57-8.62) and in coastal areas 6.70% (95%CI: 6.68-6.72) compared to the mountainous ones, which is 8.91% (95%CI:8.88-8.94).
CONCLUSIONS: The results denote a high prevalence of hypothyroidism in the adult population of Andalusia compared to the nearby countries, with a clear increased associated with females and age. Furthermore, the prevalence of the illness presents also a geographically-related variability.

Entities:  

Keywords:  Geographic Factors; Hypothyroidism; Pharmacoepidemiology; Prevalence; Sex Ratio; Spain; Thyroxine

Mesh:

Substances:

Year:  2016        PMID: 27906155

Source DB:  PubMed          Journal:  Rev Esp Salud Publica        ISSN: 1135-5727


  4 in total

1.  Adherence to dietary treatment and clinical factors associated with anti-transglutaminase antibodies in celiac disease during the follow-up.

Authors:  Marta Miró; Manuel Alonso-Garrido; Manuel Lozano; Juanjo Peiró; Lara Manyes
Journal:  Heliyon       Date:  2021-04-01

2.  Drug Prescription Profiles in Patients with Polypharmacy in Spain: A Large-Scale Pharmacoepidemiologic Study Using Real-World Data.

Authors:  Miguel Ángel Hernández-Rodríguez; Ermengol Sempere-Verdú; Caterina Vicens-Caldentey; Francisca González-Rubio; Félix Miguel-García; Vicente Palop-Larrea; Ramón Orueta-Sánchez; Óscar Esteban-Jiménez; Mara Sempere-Manuel; María Pilar Arroyo-Aniés; Buenaventura Fernández-San José; José Ignacio de Juan-Roldán; Ignatios Ioakeim-Skoufa
Journal:  Int J Environ Res Public Health       Date:  2021-04-29       Impact factor: 3.390

3.  Prevalence and factors associated with chronic use of levothyroxine: A cohort study.

Authors:  Camilla Janett-Pellegri; Lea Wildisen; Martin Feller; Cinzia Del Giovane; Elisavet Moutzouri; Oliver Grolimund; Patrick Walter; Gérard Waeber; Pedro Marques-Vidal; Peter Vollenweider; Nicolas Rodondi
Journal:  PLoS One       Date:  2021-12-20       Impact factor: 3.240

4.  Mood Disorders in Levothyroxine-Treated Hypothyroid Women.

Authors:  Benjamín Romero-Gómez; Paula Guerrero-Alonso; Juan Manuel Carmona-Torres; Blanca Notario-Pacheco; Ana Isabel Cobo-Cuenca
Journal:  Int J Environ Res Public Health       Date:  2019-11-28       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.